Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.
Recruiting
N/A
Interventional Study
Familial Hypercholesterolemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 2,000 (estimated)
- Sponsor
- Odense University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Familial hypercholesterolemia is the most common inherited disease of the lipid metabolism, however it remains underdiagnosed. Only 15 % of 30.000 possible patients have been found in Denmark. This quality assessing project will through a step wedge cluster randomized controlled trial evaluate establishment of a biochemistry interpretive comment on elevated LDL-C levels. The study will test if the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All referred patients to the lipid clinics of Southern Denmark
* LDL-C ≥ 4 mmol/L in persons under the age of 40.
* LDL-C ≥ 5 mmol/L in persons ≥ 40 years.
Exclusion Criteria:
Pregnancy and Secondary dyslipidemia
* Dysregulated diabetes. Hba1C \< 48
* Dysregulated hypothyre…
Contacts